XML 17 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover Page - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Mar. 25, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-39430    
Entity Registrant Name ACUTUS MEDICAL, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 45-1306615    
Entity Address, Address Line One 2210 Faraday Ave.    
Entity Address, Address Line Two Suite 100,    
Entity Address, City or Town Carlsbad    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92008    
City Area Code 442    
Local Phone Number 232-6080    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol AFIB    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 26.0
Entity Common Stock, Shares Outstanding   29,715,962  
Documents Incorporated by Reference
Part III of this Annual Report on Form 10-K incorporates certain information by reference from the definitive proxy statement for the Registrant’s 2024 Annual Meeting of Stockholders to be filed within 120 days of the Registrant’s fiscal year ended December 31, 2023 (the “Proxy Statement”). Except with respect to information specifically incorporated by reference in this Form 10-K, the Proxy Statement is not deemed to be filed as part of this Form 10-K.
   
Amendment Flag false    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001522860    
Document Fiscal Year Focus 2023